α‐Lipoic Acid‐Based Nanozyme for Treating Acute Epilepsy
Authors:
- 11 December 2024
- journal article
- research article
- Published by Wiley in Advanced Functional Materials
- Vol. 35 (3)
Abstract
Anti‐epilepsy drugs (AEDs), a common therapeutic approach for clinically treating epilepsy, suffer from low permeability toward the blood‐brain barrier (BBB), side effect risks, and a failure to regulate the pathological microenvironment. These issues hinder the complete control of epilepsy and lead to a vicious cycle of inflammation‐epileptogenesis. Herein, an α‐lipoic acid (LA)‐based nanozyme that loads phenytoin (PHT) and complexes calcium ions (LA@PHT‐Ca2+) is developed. This nanozyme combines the functions of delivering AEDs across the BBB and regulating undesirable microenvironments to treat epilepsy. Amphipathic LA self‐assembles into stable nanoparticles in water with BBB crossing ability endowed by the transporting of LA through sodium‐dependent multivitamin transporter. LA's enzyme‐like and redox functions provide LA@PHT‐Ca2+ with excellent scavenging effects on several free radicals via cascade reactions, thereby protecting neurons from oxidative stress. Moreover, Ca2+ disrupts neuronal respiration, resulting in reduced production of bioenergetic adenosine triphosphate and an improved hypoxic microenvironment. This leads to decreased expression of P‐glycoprotein, a drug‐efflux gating protein. This novel lipoic acid‐based nanozyme, with intrinsic BBB crossing capability, prolonged intracellular drug retention time, and the ability to block the inflammation‐epileptogenesis cycle, presents a satisfactory therapeutic effect in epileptic rats, resulting in attenuated symptoms and an improved microenvironment.Keywords
Funding Information
- National Key Research and Development Program of China (2021ZD0201602)
This publication has 46 references indexed in Scilit:
- A Cardiac‐Targeted Nanozyme Interrupts the Inflammation‐Free Radical Cycle in Myocardial InfarctionAdvanced Materials, 2023
- A Coenzyme‐Based Deep Eutectic Supramolecular Polymer BioadhesiveAdvanced Functional Materials, 2023
- Ultrasmall Coordination Polymer Nanodots Fe‐Quer Nanozymes for Preventing and Delaying the Development and Progression of Diabetic RetinopathyAdvanced Functional Materials, 2023
- Calcium Phosphate‐Based Nanoformulation Selectively Abolishes Phenytoin Resistance in Epileptic Neurons for Ceasing SeizuresSmall, 2023
- Iron-doped cross-linked lipoic acid nano-aggregates for ferroptosis-mediated cancer treatmentActa Biomaterialia, 2023
- α-Lipoic Acid, an Organosulfur Biomolecule a Novel Therapeutic Agent for Neurodegenerative Disorders: An Mechanistic PerspectiveNeurochemical Research, 2022
- Engineered Nanoenzymes with Multifunctional Properties for Next‐Generation Biological and Environmental ApplicationsAdvanced Functional Materials, 2021
- Biomimetic Design of Mitochondria‐Targeted Hybrid Nanozymes as Superoxide ScavengersAdvanced Materials, 2021
- Chemical molecular‐based approach to overcome multidrug resistance in cancer by targeting P‐glycoprotein (P‐gp)Medicinal Research Reviews, 2020
- An Organelle‐Specific Nanozyme for Diabetes Care in Genetically or Diet‐Induced ModelsAdvanced Materials, 2020